Singular Genomics Systems, Inc. (OMIC)
| Previous Close | 0.4071 |
| Open | 0.4083 |
| Bid | 0.3850 x 100 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.3800 - 0.4101 |
| 52 Week Range | 0.3100 - 1.2100 |
| Volume | |
| Avg. Volume | 113,469 |
| Market Cap | 29.627M |
| Beta (5Y Monthly) | 1.40 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.3000 |
| Earnings Date | May 09, 2024 - May 13, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.85 |
GlobeNewswireSingular Genomics to Report First Quarter 2024 Financial Results on May 14, 2024
SAN DIEGO, May 01, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today announced that it will report financial results for the first quarter ended March 31, 2024 after the market close on Tuesday, May 14, 2024. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. East
Insider MonkeySingular Genomics Systems, Inc. (NASDAQ:OMIC) Q4 2023 Earnings Call Transcript
Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q4 2023 Earnings Call Transcript March 18, 2024 Singular Genomics Systems, Inc. beats earnings expectations. Reported EPS is $-0.32, expectations were $-0.34. OMIC isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, everyone, and […]
- Thomson Reuters StreetEvents
Q4 2023 Singular Genomics Systems Inc Earnings Call
Q4 2023 Singular Genomics Systems Inc Earnings Call
